Can a Pap smear be performed safely in a woman using a vaginal contraceptive ring (e.g., NuvaRing) without removing the ring, and are any modifications to the screening protocol required?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pap Smear with Vaginal Ring

The vaginal contraceptive ring does not need to be removed to perform a Pap smear, and no modifications to the standard cervical cancer screening protocol are required.

Standard Screening Protocol Applies

The available guidelines addressing cervical cancer screening do not identify the presence of a vaginal contraceptive ring as a factor requiring special consideration or protocol modification. 1, 2 The sequence of specimen collection and the presence of vaginal devices have been specifically addressed in screening guidelines:

  • The sequence of cytology testing in relation to collection of other cervicovaginal specimens does not influence Pap test results or their interpretation. 1, 2
  • Standard cervical cancer screening intervals and techniques remain unchanged regardless of contraceptive method used. 2, 3

Practical Considerations During the Examination

While the ring does not interfere with specimen collection, certain practical steps optimize the procedure:

  • If mucopurulent discharge is present, the Pap test can be performed after careful removal of the discharge with a saline-soaked cotton swab. 1, 2 This same principle applies if the ring causes any vaginal discharge—simply remove excess discharge before specimen collection.
  • The ring sits in the vaginal fornix and should not obstruct visualization of the cervix during speculum examination. 4, 5
  • If the ring temporarily interferes with cervical visualization, it can be briefly displaced within the vagina without removal, as the ring can be out of position for up to 3 hours without compromising contraceptive efficacy. 6

No Impact on Specimen Quality

The presence of the vaginal ring does not affect:

  • Cytology specimen adequacy or interpretation. 1
  • HPV testing, which can be performed using the same specimen collection techniques. 1, 2
  • The reliability of screening results. 2

Common Pitfall to Avoid

Do not delay or postpone cervical cancer screening because a patient is using a vaginal contraceptive ring. The ring's presence is not listed among conditions that warrant postponement of cytology testing (unlike active menstruation with conventional cytology). 1, 2 Unnecessary removal and reinsertion of the ring creates an opportunity for user error and potential contraceptive failure without providing any benefit to specimen quality.

References

Guideline

sexually transmitted diseases treatment guidelines, 2010.

MMWR Recommendations and Reports, 2010

Guideline

sexually transmitted infections treatment guidelines, 2021.

MMWR Recommendations and Reports, 2021

Research

The contraceptive vaginal ring.

Seminars in reproductive medicine, 2010

Research

Vaginal ring contraception.

Contraception, 2011

Guideline

Contraceptive Vaginal Rings

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Does tirzepatide (Mounjaro) reduce the contraceptive efficacy of the NuvaRing (ethinyl estradiol/etonogestrel vaginal ring)?
Can the vaginal contraceptive ring (NuvaRing) cause recurrent vulvovaginal candidiasis?
Does a patient using a NuvaRing (etonogestrel/releasing intrauterine system) need to remove it for one week when changing to a new one?
Is there data on the risk of toxic shock syndrome associated with the vaginal contraceptive ring (NuvaRing, etonogestrel/ethinyl estradiol)?
Can the vaginal contraceptive ring (Gynoring) cause increased vaginal discharge?
What is the appropriate indication, dosage, and duration of Neurobion Forte (high‑strength B‑complex: thiamine 100 mg, pyridoxine 100 mg, cyanocobalamin 500 µg) for an adult with suspected vitamin B1, B6 or B12 deficiency or peripheral neuropathy?
In a patient with diabetes and peripheral neuropathy, can Neurobion Forte (thiamine 100 mg, pyridoxine 100 mg, cyanocobalamin 500 µg) be used safely without worsening glycemic control, and what is the recommended dosing?
What is the maximum safe dose of levosalbutamol (a β2‑agonist) that can be administered by nebulisation in children, adolescents, and adults?
Is pitavastatin 2 mg comparable to rosuvastatin 5 mg for LDL‑cholesterol lowering in adults without renal or hepatic impairment or statin intolerance?
What information can be gleaned from the two MRI reports?
What are the key findings and recommended management from the brain and cervical spine magnetic resonance imaging reports showing an incidental right frontal convexity meningioma with minimal mass effect, linear morphea‑related scalp atrophy, and a straightened cervical lordosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.